Latest Entries

The Affordable Care Act, Part Two: Prescription Drug Prices, Medicare Part D and Billy Tauzin

This is the second of two blog posts which discuss the role that corporate influence and campaign contributions played in the development and passage of the Patient Protection and Affordable Care Act, also known as Obamacare. This post discusses the influence of the pharmaceutical industry in shaping federal legislation, including the PPACA, to prevent the … Continue reading

An Introduction

The United States of America currently faces a number of complex and pressing issues, including an economy reeling from a financial crisis, a high level of unemployment, a healthcare system that leaves millions without access to vital medical treatment, and the lingering spectre of global warming. Each of these issues must be effectively addressed if … Continue reading